GSEA of Gene Ontology (GO) pathways revealed enrichment of cell cycle progression gene sets in tumors harboring ZNRF3 loss (Fig. 5B), which validated in two independent cohorts of both localized and metastatic prostate cancer (Fig. S12A, B). The gene discussed is ZNRF3; the disease is metastatic prostate carcinoma.